Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade speci...
The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-...
An interdisciplinary group of scientists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Re...
University of Birmingham women’s cancer expert Dr Sudha Sundar has been chosen as the President-Elect of the Briti...
rfxcel, the global leader in track and trace solutions, releases enhancements to its compliance solution for Russia and ...
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...
Global pharmaceutical company Mylan N.V. has announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the f...
Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare disea...
MIT researchers, including one of Indian-origin, have developed novel machine-learning techniques to improve the quality...
Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medicati...
Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer ...
Singapore- Astellas Pharma and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company he...
Singapore- OncoCyte Corporation, a developer of novel, non-invasive liquid biopsy tests for the early detection of cance...
Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genom...
Researchers have found that a group of viruses that cause severe stomach illness — including the one famous for wi...
Lixte Biotechnology Holdings, Inc. has announced the appointments of two new members to the Board of Directors of Lixte;...
The U.S. Food and Drug Administration approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for th...
